This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

Clinical trial NCT07412405 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07412405
Sponsor: GUSTAVO SALGUERO
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Adult B-cell Acute Lymphoblastic Leukemia Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia

Start date: 2026-09-01
Primary completion: 2028-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.